New QRICH1 Gene Change Linked To Ververi-Brady Syndrome
This paper described one infant boy with Ververi-Brady syndrome who presented with infantile epileptic spasms syndrome.
This hub covers epilepsy genetics: how gene changes can contribute to seizures (often in children). We translate studies on testing, results like VUS, and what findings may change for care.
No. It’s common in pediatrics, but adults can benefit from genetic testing, too, especially with unclear diagnosis or family history.
Sometimes. For certain conditions, results can guide medication choice, diet therapies, or referral decisions.
It usually means “not enough evidence yet.” It shouldn’t be treated as a definite cause, but it can be reclassified over time.
Not necessarily. Testing can miss some variants, and new gene links are still being discovered.
This paper described one infant boy with Ververi-Brady syndrome who presented with infantile epileptic spasms syndrome.
This paper was a systematic review, which means the authors gathered and analyzed results from earlier studies rather than testing one new device in patients.
This study looked at whether resting-state functional MRI (rs-fMRI) could help identify language lateralization before epilepsy surgery.
This report described 2 pediatric patients with Dravet syndrome associated with SCN1A variants who were treated with cenobamate as an add-on antiseizure medicine.
This study looked at whether magnetoencephalographic source imaging (MSI) adds diagnostic value for finding the brain area where seizures start in people with drug-resistant focal epilepsy.
This study asked a panel of 28 stakeholders from European Union countries and the UK to give their views about what “seizure freedom” should mean in epilepsy care and research, and why it matters.
This study looked at how specialized Italian neuroscience and neuro-rehabilitation centers organize care for people with brain tumour-related epilepsy.
This study looked at KCNT1-related epilepsy in infancy.
Researchers studied cannabidiol (CBD) in a lab rat model of malformation of cortical development (MCD), a brain development problem linked to hard-to-treat epilepsy.